Calamos Advisors LLC Artivion, Inc. Transaction History
Calamos Advisors LLC
- $15.7 Billion
- Q1 2025
A detailed history of Calamos Advisors LLC transactions in Artivion, Inc. stock. As of the latest transaction made, Calamos Advisors LLC holds 54,000 shares of AORT stock, worth $1.3 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
54,000
Previous 63,029
14.33%
Holding current value
$1.3 Million
Previous $1.81 Million
26.81%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding AORT
# of Institutions
177Shares Held
35.8MCall Options Held
29.9KPut Options Held
2.3K-
Black Rock Inc. New York, NY6.64MShares$159 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$67.3 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$67 Million2.68% of portfolio
-
Macquarie Group LTD Australia, C32.74MShares$65.7 Million0.09% of portfolio
-
Morgan Stanley New York, NY2.36MShares$56.6 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $967M
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...